Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01450020 · ClinicalTrials.gov registry record · NA

Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors

A NA study of Breast Cancer, sponsored by City of Hope Medical Center.

Active
Registry status
NA
Development phase
145
Enrollment target
1
Study location

NCT01450020: Active NA study of Breast Cancer, sponsored by City of Hope Medical Center.

NCT01450020 is a NA study of Breast Cancer that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 145 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01450020, a NA study of Breast Cancer, is active but no longer recruiting, sponsored by City of Hope Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
145 participants
Enrollment target
1
Study location

Study Summary

This randomized clinical trial studies peer navigator education in improving survivorship care in African American breast cancer survivors. An educational intervention involving peer groups may help to improve the well-being and quality of life (QOL) in breast cancer survivors

Primary Outcome

Chi-square and t-tests will be used to compare the baseline characteristics of subjects randomized to PN intervention vs control. For subjects in the intervention arm, the number of navigation sessions received will be reported, and correlated factors will be explored. The number of subjects navigated per PN will also be reported. Nonevaluable and evaluable subjects (defined at 6 and 12 months) will be compared. Site of care will be handled as a cluster level variable in generalized linear mixed

Conditions Studied

Interventions

  • OTHER questionnaire administration
  • OTHER survey administration
  • PROCEDURE quality-of-life assessment
  • OTHER educational intervention
  • OTHER counseling intervention

Study Locations (1)

California

  • City of Hope Medical Center - Duarte

Trial Details

FieldValue
Enrollment Target 145 participants
Start Date 2012-06-01
Est. Completion 2025-12-30
Phase NA
City of Hope Medical Center

582 total trials

What the registry record for NCT01450020 still lists

NCT01450020 is an interventional study that assigns participants to a tested intervention. The registered 145 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which questionnaire administration is the first listed.

NCT01450020 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01450020 about?

NCT01450020 is a clinical study titled "Peer Navigator Education in Improving Survivorship Care in African American Breast Cancer Survivors". This randomized clinical trial studies peer navigator education in improving survivorship care in African American breast cancer survivors. An educational intervention involving peer groups may help to improve the well-being and quality of life (QOL) in breast cancer survivors

What is the current status of trial NCT01450020?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 145 participants. The study started on 2012-06-01. Estimated completion is 2025-12-30.

What conditions does trial NCT01450020 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT01450020?

The interventions under investigation include: questionnaire administration (OTHER), survey administration (OTHER), quality-of-life assessment (PROCEDURE), educational intervention (OTHER), counseling intervention (OTHER).

Who is sponsoring clinical trial NCT01450020?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01450020 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01450020's enrollment target sits among peer trials

145 456th of 1224 higher than 766 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02688959 · 145 participants · NA

    Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)

  • NCT03586609 · 145 participants · Phase 2

    Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia

  • NCT03767595 · 145 participants · NA

    ProACT Post-Approval Study

  • NCT03808337 · 145 participants · Phase 2

    Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01450020, the US trial registry maintained by the National Library of Medicine. NCT01450020 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.